Loading...
By Kelly Young
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
Fecal microbiota transplantation (FMT) carries a potential risk for serious infections caused by enteropathic Escherichia coli and Shiga toxin-producing E. coli, the FDA cautioned.
Six patients who received investigational FMT for Clostridioides difficile infection subsequently developed these infections. Four were hospitalized. In addition, two other patients died after receiving FMT from one of the donors associated with the other infections. These two patients developed diarrhea after FMT, but their stool wasn't tested for E. coli.
Comment
LINK(S):
FDA MedWatch safety alert (Free)
Background: NEJM Journal Watch Infectious Diseases coverage of NEJM studies on infections associated with FMT (Your NEJM Journal Watch subscription required)